Pharmaceutical Sales Company Deploys Work in 2017
Release time:
2020-08-14
Pharmaceutical Sales Company Deploys 2017 Work
News 1# September 15 , 24 , Peak Pharmaceutical Sales Company successively held terminal and agent annual summary meetings to review 2016 and deploy 2017 Work. At the terminal sales summary meeting held on January 15
2016 , summarizing the gains and losses of the work, analyzing the existing problems and exchanging the work plan for the new year. Xu Junxiong, executive deputy general manager of Pharmaceutical Sales Company, summarized the overall situation of terminal sales from the aspects of sales performance, specific work and existing problems. Focusing on the work focus of "increasing incentives, emphasizing academics and strengthening promotion", he made arrangements for the work of 2017 in terms of incentive mechanism, team building, bidding and bargaining, marketing innovation and academic promotion, and read out the 2017 terminal sales target decomposition plan and assessment criteria. Jin Xuecai, deputy general manager of Pharmaceutical Company and general manager of Pharmaceutical Sales Company, commented on the advantages and disadvantages of terminal sales 2016 at the meeting. According to the current development trend of the pharmaceutical industry, he asked all offices to seize the opportunity of medical insurance adjustment and strengthen hospital development. Strengthen communication and visit to achieve sales volume; Increase academic promotion and actively respond to trend changes; salesmen should strengthen their own training and learning, strengthen the internal management of the office; innovate the sales model and do a good job in terminal sales. At the
meeting, the level of salesmen was also evaluated according to their work performance, the collectives and individuals who won the annual sales competition award were commended, and the annual sales responsibility system was signed with each office. At the agency sales meeting held on January 24 , each regional manager summarized and reported the work in the first half of the year from the aspects of product sales, new customer development, existing problems, new year's work and goal realization. Regional managers and managers evaluate the reporter from five aspects, such as enterprise loyalty, sales performance over the years, annual sales performance, and market development ability, and ask questions about the main points of the report.
The meeting discussed and approved a new regional manager incentive and appraisal plan, announced the decision to merge several regions with smaller sales, and conducted a regional manager competition. Participants are ranked by the evaluation scores obtained in the previous report. The top ten regional managers give priority to regional bargaining. After three rounds of bidding, the competition results are finally determined. At the agent sales meeting, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, analyzed the current situation of the pharmaceutical industry from many aspects and pointed out the challenges and opportunities. He said that the incentive policy for regional managers will be adjusted, and he hopes that all regions will have a deep understanding of the new policy and resolutely implement it. Jiang Xiaomeng, chairman of
group company and chairman of pharmaceutical company, attended the agency sales meeting and delivered a speech. He commented on the agency sales work, pointed out that some personnel have problems such as lack of self-confidence, low morale, few methods, and serious inert thinking. Pharmaceutical sales companies are required to organize various trainings in a targeted manner, and sales personnel should also strengthen learning., Improve their own sales skills, think carefully according to the life cycle and sales strategy of the company's key products, and solve the problems in sales. (Ni Yingzhen Xu Xianzhong)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page